G Beaumont

651 total citations
52 papers, 387 citations indexed

About

G Beaumont is a scholar working on Pharmacology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, G Beaumont has authored 52 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 18 papers in Psychiatry and Mental health and 7 papers in Clinical Psychology. Recurrent topics in G Beaumont's work include Treatment of Major Depression (13 papers), Schizophrenia research and treatment (11 papers) and Attention Deficit Hyperactivity Disorder (6 papers). G Beaumont is often cited by papers focused on Treatment of Major Depression (13 papers), Schizophrenia research and treatment (11 papers) and Attention Deficit Hyperactivity Disorder (6 papers). G Beaumont collaborates with scholars based in United Kingdom, France and Austria. G Beaumont's co-authors include J Seldrup, G. C. Dunbar, Tracey Lintern, Pamela Kenealy, David S. Baldwin, W. Hetzel, Malcolm Lader, David Healy, S. I. Ankier and Paul M. Miller and has published in prestigious journals such as The Lancet, The British Journal of Psychiatry and Psychopharmacology.

In The Last Decade

G Beaumont

48 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Beaumont United Kingdom 11 148 144 90 75 53 52 387
J. J. López-Ibor Spain 8 138 0.9× 122 0.8× 49 0.5× 46 0.6× 37 0.7× 21 312
John E. Crowder United States 8 184 1.2× 142 1.0× 113 1.3× 51 0.7× 53 1.0× 14 356
J. Andersen Denmark 10 119 0.8× 204 1.4× 84 0.9× 82 1.1× 35 0.7× 16 370
G. Eberhard Sweden 10 105 0.7× 134 0.9× 81 0.9× 89 1.2× 47 0.9× 15 468
Rosenbaum Jf United States 9 93 0.6× 149 1.0× 122 1.4× 120 1.6× 40 0.8× 21 375
M Ferreri France 10 172 1.2× 249 1.7× 128 1.4× 90 1.2× 36 0.7× 34 430
James T. Hartford United States 11 196 1.3× 161 1.1× 188 2.1× 132 1.8× 36 0.7× 16 463
M.T. Abou‐Saleh United Kingdom 12 157 1.1× 273 1.9× 60 0.7× 145 1.9× 17 0.3× 17 565
Cohn Jb United States 9 222 1.5× 157 1.1× 124 1.4× 27 0.4× 70 1.3× 14 367
Eugene H. Makela United States 12 84 0.6× 225 1.6× 56 0.6× 70 0.9× 86 1.6× 21 529

Countries citing papers authored by G Beaumont

Since Specialization
Citations

This map shows the geographic impact of G Beaumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Beaumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Beaumont more than expected).

Fields of papers citing papers by G Beaumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Beaumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Beaumont. The network helps show where G Beaumont may publish in the future.

Co-authorship network of co-authors of G Beaumont

This figure shows the co-authorship network connecting the top 25 collaborators of G Beaumont. A scholar is included among the top collaborators of G Beaumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Beaumont. G Beaumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mosing, Martina, Anthea L. Raisis, Adam Auckburally, et al.. (2024). Characterization of dynamic compliance of the respiratory system in healthy anesthetized dogs. Frontiers in Veterinary Science. 11. 1490494–1490494.
2.
3.
Kenealy, Pamela, et al.. (2000). Autobiographical Memory, Depression and Quality of Life in Multiple Sclerosis. Journal of Clinical and Experimental Neuropsychology. 22(1). 125–131. 28 indexed citations
4.
Beaumont, G. (2000). Antipsychotics – The Future of Schizophrenia Treatment. Current Medical Research and Opinion. 16(1). 37–42. 12 indexed citations
5.
Beaumont, G. (2000). Antipsychotics - The Future of Schizophrenia Treatment. Current Medical Research and Opinion. 16(1). 37–42. 4 indexed citations
6.
Nutt, David, David S. Baldwin, G Beaumont, et al.. (1999). Guidelines for the management of social phobia/social anxiety disorder. Research Explorer (The University of Manchester). 3 indexed citations
7.
Beaumont, G, Siegfried Kasper, J. F. O’Hanlon, & Julien Mendlewicz. (1994). Antidepressant side effects and adverse reactions. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 2(3). 138–144. 2 indexed citations
8.
9.
Dunbar, G. C., et al.. (1992). The SmithKline Beecham ?quality of life? scale: a validation and reliability study in patients with affective disorder. Quality of Life Research. 1(6). 385–395. 48 indexed citations
10.
Beaumont, G, et al.. (1990). Mequitazine in the treatment of hayfever. International Journal of Clinical Practice. 44(5). 183–188. 3 indexed citations
11.
Beaumont, G, et al.. (1984). Electrophysiological responses in high and low aggressive young adolescent boys.. PubMed. 50(4). 179–90. 2 indexed citations
12.
Beaumont, G & J Seldrup. (1980). Comparative trial of clomipramine and placebo in the treatment of terminal pain.. PubMed. 8 Suppl 3. 67–9. 6 indexed citations
13.
Beaumont, G, et al.. (1977). A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.. PubMed. 5(1 Suppl). 119–24. 4 indexed citations
14.
Beaumont, G, et al.. (1977). An Evaluation of Andursil – A New Antacid. Journal of International Medical Research. 5(6). 99–104. 27 indexed citations
15.
Beaumont, G. (1975). A New Rating Scale for Obsessional and Phobic States. Scottish Medical Journal. 20(1_suppl). 25–32. 5 indexed citations
16.
Beaumont, G. (1973). Oral and Intravenous Clomipramine (Anafranil) in Depression: A Review of the Work of Dr. G. H. Collins. Journal of International Medical Research. 1(5). 361–364. 1 indexed citations
17.
Waxman, David J. & G Beaumont. (1972). A Comparative Trial of Insidon and Stelazine in the Treatment of Anxiety. Journal of International Medical Research. 1(1). 22–25. 4 indexed citations
18.
Beaumont, G, et al.. (1971). A Double‐blind Comparison of Opipramol and Diazepam in the Treatment of Anxiety in General Practice. International Journal of Clinical Practice. 25(10). 455–458. 2 indexed citations
19.
Beaumont, G, et al.. (1969). Opipramol and trifluoperazine in the treatment of anxiety and tension.. PubMed. 17(83). 395–400. 2 indexed citations
20.
Jelliffe, A.M., et al.. (1951). A.C.T.H. BY INTRAVENOUS INFUSION. The Lancet. 257(6667). 1260–1261. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. J. López-Ibor Breakdown of academic impact, for papers by John E. Crowder Breakdown of academic impact, for papers by J. Andersen Breakdown of academic impact, for papers by G. Eberhard Breakdown of academic impact, for papers by Rosenbaum Jf Breakdown of academic impact, for papers by M Ferreri Breakdown of academic impact, for papers by James T. Hartford Breakdown of academic impact, for papers by M.T. Abou‐Saleh Breakdown of academic impact, for papers by Cohn Jb Breakdown of academic impact, for papers by Eugene H. Makela
Rankless by CCL
2026